HealthcareNasdaqsmall
Institutional-grade research for retail investors
SEC EDGAR: CIK 1680367STTK stock profile & AI dashboard →

13F Pro Quality Score

15.0/100

Rank #2,857 of 2,962 stocks

View Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.

Email me the moment this company reports earnings
AI Research Report
Two-page plain-English analysis: business, thesis, and three scenarios for the next two years. Refreshed every quarter.
Upgrade to Pro
Pro: 5 reports/month · Pro+: unlimitedOpinion, not investment advice. Do your own research.

STTK Stock Analysis & AI Quality Score

Data updated 2026-09-11

AI stock analysis and institutional research for Shattuck Labs, Inc. (STTK), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores STTK at 15.0/100 on a 32-signal composite quality model, placing it at rank #2,857 of 2,962 stocks — the bottom half of the AI-ranked universe. Top institutional holders of STTK by reported 13-F value include T. Rowe Price Investment Management, ADAGE CAPITAL PARTNERS GP, L.L.C., Redmile Group, based on the most recent SEC filings. STTK trades on the Nasdaq exchange and files with the SEC under CIK 1680367. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate STTK daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Shattuck Labs, Inc. directly from SEC EDGAR. Shattuck Labs, Inc.'s 13F Pro composite quality score has ranged between 3 and 29 since 2021, currently 15.0 — an improving long-term trajectory across 24 quarterly and live scoring snapshots.

Revenue

Q2 2026

$0.00

Net Income

Q2 2026

$-15.2M

ROIC

Q2 2026

-30.6%

Period

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro

Revenue

-82.5% YoY
$1.0MFY 2025
FY22 $652.0KFY23 $1.7MFY24 $5.7MFY25 $1.0M

Net Income

+35.3% YoY
$-48.8MFY 2025
FY22 $-101.9MFY23 $-87.3MFY24 $-75.4MFY25 $-48.8M

Operating Income

+36.1% YoY
$-51.5MFY 2025
FY22 $-103.3MFY23 $-92.0MFY24 $-80.6MFY25 $-51.5M

EPS (Diluted)

+53.0% YoY
$-0.70FY 2025
FY22 $-2.41FY23 $-2.05FY24 $-1.49FY25 $-0.70

Total Assets

-0.0% YoY
$91.0MFY 2025
FY22 $205.3MFY23 $159.6MFY24 $91.0MFY25 $91.0M

Op. Cash Flow

+34.1% YoY
$-39.9MFY 2025
FY22 $-94.5MFY23 $-81.2MFY24 $-60.5MFY25 $-39.9M

Free Cash Flow

+34.0% YoY
$-40.0MFY 2025
FY22 $-106.1MFY23 $-81.6MFY24 $-60.6MFY25 $-40.0M

Get alerted when STTK's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for Shattuck Labs, Inc. including:

SEC EDGAR filings (10-K, 10-Q, 8-K)
XBRL financial facts (revenue, EPS, margins)
Insider transactions (Form 4)
Institutional 13F holdings
Quality rankings (32 signals)
AI analyst debates & daily meetings
Historical financial trends
Peer comparison & sector analysis

Top Institutional Holders of STTK

Put STTK on your watchlist

Track score changes the day Shattuck Labs, Inc. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Is STTK a good stock to buy?

13F Pro's AI-powered analysis of Shattuck Labs, Inc. (STTK) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for STTK are available on the STTK stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. STTK is classified as a small company.

Which hedge funds own STTK?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling STTK. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of Shattuck Labs, Inc.'s investment landscape.